Steven Elliott Feldon, MD, MBA | oneGRAVESvoice

welcome to oneGRAVESvoice

- a positively charged Graves' disease and thyroid eye disease community.
  • join today!
Healthcare Professionals

Steven Elliott Feldon, MD, MBA

Healthcare Professional
Director
Flaum Eye Institute
University of Rochester Medical Center
601 Elmwood Avenue
Rochester, New York, United States

Steven Elliott Feldon is an internationally acclaimed clinical and basic scientist with a specialty in orbital disease and neuro-ophthalmology. In 2001, he was appointed Chair of the University of Rochester Department of Ophthalmology, and is now Director of the Flaum Eye Institute.

Dr. Feldon earned his medical degree from the Albert Einstein College of Medicine. He completed his residency at the Massachusetts Eye & Ear Infirmary, Harvard University, along with a research fellowship in neurosurgery at Massachusetts General Hospital, and a clinical fellowship in neuro-ophthalmology at the University of California Medical Center, San Francisco.

Devoted to patient care, Dr. Feldon’s special interest is in the management of patients with thyroid-associated eye disease. Cranial nerve palsies, disorders of the optic nerve, visual field loss, and eye movement problems are all his specialty areas. Now leading a world-class team of eye care specialists, his clinical expertise has been recognized in “Best Doctors in America.” 

An inventor of ophthalmic instruments and a scientific investigator, Dr. Feldon is involved in a number of local and national clinical trials and basic science collaborations. He is the former President of the North American Neuro-Ophthalmic Society and the current Executive Vice President of the Association of University Professors of Ophthalmology. 

 

Representative Publications:

Axial Globe Position Measurement: A Prospective Multicenter Study by the International Thyroid Eye Disease Society

Retinal and Choroidal Folds in Papilledema

Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results

Graves’ Ophthalmopathy: III. Effect of Transantral Orbital Decompression on Optic Neuropathy

Font Resize

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close